𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of biological activity of synthetic fragments of transforming growth factor-alpha

✍ Scribed by Krzysztof Darlak; Glen Franklin; Philip Woost; Elaine Sonnenfeld; Daniel Twardzik; Arno Spatola; Gregory Schultz


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
629 KB
Volume
36
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Transforming growth factor-alpha (TGF-a) is a single chain polypeptide hormone of 50 amino acids that stimulates growth of some human cancer cells via an autocrine mechanism. The domain(s) of TGF-a that bind and activate its receptor have not been reported. Hydrophilicity plots of TGF-(r indicate three discrete sequences that are theoretically exposed on the hormone's surface and thus potentially able to interact with the TGF-(r receptor. Fragments of TGF-(r encompassing these hydrophilic domains were prepared by using solid-phase peptide synthesis (SPPS) techniques and purified by use of high performance liquid chromotography (HPLC). Assessment of biological activity of the TGF-a fragments indicated that none of the fragments significantly inhibited binding of EGF to the receptor, stimulated DNA synthesis of cells, inhibited EGF-induced DNA synthesis of cells, stimualted growth of cells in soft agar, or induced phosphorylation of the receptor or p35 protein. These results indicate that the receptor binding domain of TGF-a is not totally encompassed by any of the separate fragments tested and probably is formed by multiple separate regions of TGF-a.


πŸ“œ SIMILAR VOLUMES


Transforming growth factor-alpha short-c
✍ Xiaomei Ouyang; Timothy Gulliford; Guocai Huang; Richard J. Epstein πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

Transforming growth factor-alpha (TGF␣) is an epidermal growth factor receptor (EGFR) ligand which is distinguished from EGF by its acid-labile structure and potent transforming function. We recently reported that TGF␣ induces less efficient EGFR heterodimerization and downregulation than does EGF (

Modulation of transforming growth factor
✍ J. A. Fernandez-Pol; D. J. Klos; P. D. Hamilton πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 692 KB

We have investigated the actions of transforming growth factor (TGF) type a on epidermal growth factor (EGF) receptor mRNA expression in MDA-468 human mammary carcinoma cells in serum-free media. We found that exposure of MDA-468 cells to TGFa results in elevated levels of EGF receptor mRNA. This in

Prolactin induced expression of interleu
✍ Dr. William J. DeVito; Crystal Avakian; Scot Stone; William C. Okulicz; Kam-Tsun πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 854 KB

Prolactin (PRL) is a potent mitogen in cultured astrocytes. Because one of the major effects of astrocyte proliferation is the expression of inflammatory cytokines, we examined the effect of PRL-induced mitogenesis on the expression of interleukin-1 (IL-I a), tumor necrosis factor-a (TNF-a), and tra

Determination of transforming growth fac
✍ Axel-R. Hanauske; Carlos L. Arteaga; Gary M. Clark; Joy Buchok; Martha Marshall; πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 621 KB

Transforming growth factors (TGF) are polypeptides that stimulate anchorage-independent growth of various nontransformed cells in vitro. Transforming growth factors have been found in tumor extracts and in the urine of cancer patients. The specific questions of our study were whether TGF activity ca

Protection of transforming growth factor
✍ Timothy A. McCaffrey; Domenick J. Falcone; Diane Vicente; Baoheng Du; Seth Consi πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 1002 KB

## Abstract The transforming growth factor‐β (TGF‐β) family of proteins exert diverse and potent effects on proliferation, differentiation, and extracellular matrix synthesis. However, relatively little is known about the stability or processing of endogenous TGF‐β activity in vitro or in vivo. Our